Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
TQS’s data intelligence capabilities enhance Cognizant’s smart manufacturing offerings.
July 22, 2021
By: Charlie Sternberg
Cognizant has agreed to acquire TQS Integration, a privately owned global industrial data and intelligence company based in Lismore, Ireland. TQS delivers manufacturing data intelligence, global technology consulting and digital systems integration to help manufacturers accelerate their digital transformations. TQS’s data intelligence capabilities, which will be combined with Cognizant’s core Industry+ and digital competencies, use artificial intelligence (AI) and machine learning to collect, contextualize and analyze manufacturing data. This allows manufacturers to make smarter decisions and improve operating costs, speed of implementation, and product quality and yield. “TQS enhances Cognizant’s end-to-end smart factory capabilities, helping clients realize information and operational technology convergence and drive digital transformation in their manufacturing operations,” said Srinivas Shankar, senior vice president and global markets lead, Life Sciences, Cognizant. “With TQS, Cognizant not only becomes one of the industry’s most comprehensive solutions for Manufacturing 4.0 for life sciences. We also strengthen our data historian and analytics capabilities to help all our manufacturing clients harness the power of data intelligence to compete in new ways.” TQS helps nine of the top 10 global life sciences companies enable smart manufacturing. Cognizant, which previously strengthened its life sciences manufacturing capabilities with the 2019 acquisition of Zenith Technologies, will combine TQS’s expertise with its own to help clients transition to Industry 4.0 and expedite the production of life-changing medicines. These service solutions, expertise and thought leadership benefit Cognizant’s current life sciences clients, as well as clients in the broader manufacturing landscape. “Our world-class team of data intelligence and technology consultants have built a tremendous track record in helping our life sciences manufacturing clients transform their businesses,” said Máire Quilty, corporate managing director, TQS. “Together with Cognizant, we look forward to broadening our impact to manufacturing clients in other industries who are looking to embrace Industry 4.0.” TQS, a premier partner of OSIsoft, which was recently acquired by AVEVA, provides advanced solutions for OSIsoft’s Pi System, giving clients advanced data visualization and data analysis of time and historical data to help them make real-time business decisions. “The addition of TQS will further strengthen and accelerate the collaboration we have with Cognizant,” said Kerry Grimes, senior vice president and head of global partners, AVEVA. “This acquisition combines Cognizant’s rich AVEVA experience with TQS’s knowledge of OSIsoft. Similar to our recent acquisition of OSIsoft, this addresses the joint capabilities our clients need to drive their digital transformation journey. We look forward to the unique market opportunities that we can present together to our customers and partners.” TQS is Cognizant’s fifth acquisition in 2021. Since 2019, Cognizant has accelerated growth in the areas of Internet of Things, data and analytics with acquisitions, including Zenith Technologies, Bright Wolf, and ESG Mobility. TQS expands Cognizant’s presence in Ireland, a hub for the world’s leading life sciences manufacturing experts and an ideal location for delivering Industry 4.0 consulting and services to European manufacturing clients. The transaction is expected to close in the third quarter of 2021, subject to satisfaction of closing conditions. Financial details were not disclosed.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !